**Core Concept:** Tumor Necrosis Factor (TNF-α) is a pro-inflammatory cytokine that plays a crucial role in immune response, inflammation, and pathogenesis of certain diseases like rheumatoid arthritis (RA). TNF-α inhibitors are drugs that block the action of TNF-α to reduce inflammation and alleviate symptoms.

**Why the Correct Answer is Right:** Anakinra, also known as Kineret, is a recombinant human monoclonal antibody that specifically binds to and neutralizes the biological activity of human TNF-α. This leads to a decrease in inflammation, making it a TNF-α inhibitor.

**Why Each Wrong Option is Incorrect:**

A. **Option A:** Etanercept (Enbrel) is a soluble TNF-receptor fusion protein that binds to TNF-α and prevents it from interacting with its receptors, effectively inhibiting TNF-α activity. This option is incorrect as it is a TNF-receptor fusion protein, not a monoclonal antibody like Anakinra, making it a TNF-receptor fusion protein inhibitor, not an TNF-α inhibitor.

B. **Option B:** Adalimumab (Humira) is a monoclonal antibody that binds to TNF-α and prevents it from interacting with its receptors, like Etanercept. This option is also incorrect as Adalimumab is a monoclonal antibody, just like Anakinra, making it a TNF-α inhibitor.

C. **Option C:** Rituximab (Rituxan) is a monoclonal antibody targeting CD20 on B cells, which is involved in humoral immunity and B cell activation. It is not a TNF-α inhibitor.

D. **Option D:** Infliximab (Remicade) is a monoclonal antibody that binds to TNF-α and prevents it from interacting with its receptors, like Anakinra and Adalimumab. This option is also incorrect as Infliximab is a monoclonal antibody, just like Anakinra and Adalimumab, making it a TNF-α inhibitor.

**Clinical Pearl:** The correct answer is Anakinra (Anakinra is a recombinant human monoclonal antibody that binds to TNF-α and prevents it from interacting with its receptors, effectively inhibiting TNF-α activity. This helps to reduce inflammation and alleviate symptoms in autoimmune diseases such as rheumatoid arthritis (RA) and Crohn's disease.)

**Why Anakinra is Right:** Anakinra is a monoclonal antibody that specifically targets and neutralizes TNF-α, thereby blocking its interaction with its receptors. By inhibiting TNF-α activity, Anakinra is effective in reducing inflammation and improving symptoms in autoimmune diseases like rheumatoid arthritis (RA) and Crohn's disease.